Treatment of cancer with TOR kinase inhibitors
US9937170B2 · kind B2 · utility
1Cited by
35References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 27, 2016 |
| Grant date | Apr 10, 2018 |
| Priority date | — |
| Expiry date | Sep 27, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are methods for treating or preventing a solid tumor, non-Hodgkin lymphoma or multiple myeloma in a patient, comprising administering an effective amount of a TOR kinase inhibitor to a patient having a solid tumor, non-Hodgkin lymphoma or multiple myeloma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.